Secukinumab tames psoriatic arthritis in FUTURE 2 trial

BOSTON – Secukinumab improved quality of life and symptoms in patients with psoriatic arthritis, regardless of whether they had received prior anti-tumor-necrosis factor therapy or were concurrently...

Field of Interest: Rheumatology
Type: News Item

Early discoid lupus onset protective against nephritis

BOSTON - Among 839 patients with systemic lupus erythematosus (SLE) and no evidence of lupus nephritis at the time of diagnosis, the presence of discoid lupus erythematosus (DLE) at SLE onset was...

Field of Interest: Rheumatology
Type: News Item

Early discoid lupus onset protective against nephritis

BOSTON - Among 839 patients with systemic lupus erythematosus (SLE) and no evidence of lupus nephritis at the time of diagnosis, the presence of discoid lupus erythematosus (DLE) at SLE onset was...

Field of Interest: Dermatology
Type: News Item

Tapering TNFi’s safe and much cheaper in RA

BOSTON – Tapering but perhaps not completely stopping tumor necrosis factor inhibitors can result in good control of rheumatoid arthritis with considerable cost savings, according to investigators in...

Field of Interest: Rheumatology
Type: News Item

Nonsteroidal ‘DAGR’ looks sharp against RA

BOSTON – A nonsteroidal investigational drug that acts on the glucocorticoid receptor was superior to placebo and noninferior to higher-dose prednisone in adults with rheumatoid arthritis,...

Field of Interest: Rheumatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness